IDEC-CE9: IDPH and partner SmithKline Beecham began a Phase I/II trial

By WIR Staff | May 31, 1994 | 7:00 AM GMT

IDEC Pharmaceuticals Corp. (IDPH)
Product: IDEC-CE9.1, Primatized antibody directed

Read the full 94 word article

How to gain access

Continue reading with a
two-week free trial.